LETTER TO THE EDITOR


https://doi.org/10.5005/jp-journals-10071-24437
Indian Journal of Critical Care Medicine
Volume 27 | Issue 4 | Year 2023

Deliberating a Re(n)al-world Research Setting


Nitin Choudhary1https://orcid.org/0000-0002-8933-1222, Rohan Magoon2https://orcid.org/0000-0003-4633-8851, Jes Jose3https://orcid.org/0000-0003-1734-9519

1Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India

2Department of Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India

3Department of Cardiac Anaesthesiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India

Corresponding Author: Nitin Choudhary, Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India, Phone: +91 8447698566, e-mail: drnitinchoudhary86@gmail.com

How to cite this article: Choudhary N, Magoon R, Jose J. Deliberating a Re(n)al-world Research Setting. Indian J Crit Care Med 2023;27(4):297.

Source of support: Nil

Conflict of interest: None

Received on: 10 February 2023; Accepted on: 10 March 2023; Published on: 31 March 2023

Keywords: Acute kidney injury, Contrast agents, Hypoalbuminemia, Postoperative renal insult, Vasopressors.

Singh et al. are sincerely congratulated for their exemplary research endeavor assessing the spectrum of acute kidney injury (AKI) amongst non-COVID-19 patients across 200 adult patients admitted to four intensive care units (ICUs) in their tertiary care center.1 Ahead of the interesting observations on the AKI pattern emanating from the index study, there remain additional points necessitating deliberation for improved comprehension of the subject.

Firstly, the authors outline an increased incidence of community-acquired compared to hospital-acquired AKI in their setting. Quite understandably, they attribute the same to restricted surgeries during times of pandemic.1 Appropriate to the context, Boyer et al. elaborate an even more important role of the nature of surgical interventions in determining the overall predisposition to postoperative AKI.2 Withstanding, one misses the account of the type of surgeries performed in the Singh et al. prospective study. Notably, so the study involved two surgical ICUs with post-surgery being the third leading etiology with a 22.5% contribution to the AKI burden.1 Moreover, with one of the ICUs being dedicated to cardiothoracic surgical care, the operative use of cardiopulmonary bypass would have also been far from benign with regards to AKI as an outcome.1,2

Secondly, the lack of data on the diagnostic-therapeutic procedural use of contrast agents in the critically ill culminating into AKI, limits the understanding of the disease spectrum in the present study.1 Contrast administration, alongside accentuating the propensity to AKI has relevant prognostic implications highlighted by Cheng et al. in a large cohort of 2,77,898 hospitalized patients.3 Furthermore, the former group discovered elevated all-cause mortality in the post-contrast AKI subset with persistent renal dysfunction (RR; 95% CI: 3.77; 1.61–8.81, p-value = 0.002).3 Talking of mortality, Singh et al. pinpoint a heightened use of inotropes amongst the non-survivors.1 Falling short of elucidation of the nature of hemodynamic support, we believe it is a case of the use of an inclusive terminology given almost 2 out of 3 non-survivors manifested sepsis, which in all likelihood would have mandated vasopressor administration.4

Lastly, with the 30-day mortality following AKI under evaluation in the Singh et al. study, factors such as hypoalbuminemia are equally difficult to overlook considering meta-analysis by Wiedermann et al. propounds 147% increased odds of death for every 10 gm/L decrement of serum albumin in AKI patients.1,5

ORCID

Nitin Choudhary https://orcid.org/0000-0002-8933-1222

Rohan Magoon https://orcid.org/0000-0003-4633-8851

Jes Jose https://orcid.org/0000-0003-1734-9519

REFERENCES

1. Singh B, Dogra PM, Sood V, Singh V, Katyal A, Dhawan M, et al. Spectrum, outcomes, and mortality predictors of acute kidney injury among Non-COVID-19 patients during COVID-19 pandemic: Data from four intensive care units. Indian J Crit Care Med 2023; 27(2):119–126.DOI: 10.5005/jp-journals-10071-24408.

2. Boyer N, Eldridge J, Prowle JR, Forni LG. Postoperative acute kidney injury. CJASN 2022;17(10):1535–1545. DOI: 10.2215/CJN.16541221.

3. Cheng W, Wu X, Liu Q, Wang HS, Zhang NY, Xiao YQ, et al. Post-contrast acute kidney injury in a hospitalized population: Short-, mid-, and long-term outcome and risk factors for adverse events. Eur Radiol 2020; 30(6):3516–3527.DOI: 10.1007/s00330-020-06690-3.

4. Magoon R, Kaushal B, Das D, Jangid SK. Norepinephrine in sepsis: Looking beyond vasoconstriction! Indian J Crit Care Med 2019;23(11):544. DOI: 10.5005/jp-journals-10071-23280.

5. Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: A meta-analysis of observational clinical studies. Intensive Care Med 2010;36(10):1657–1665. DOI: 10.1007/s00134-010-1928-z.

________________________
© The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.